Intellectia LogoIntellectia
Product
Resources
Stock
Crypto
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategy
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns

Resources

Learn
Blog
Earnings
Tutorial
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
StockCryptoPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. HCAT
    4. >
  4. Valuation

Valuation

-
stocks logo
HCAT
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

Is HCAT Overvalued？

HCAT is now in the zone, suggesting that HCAT current forward PE ratio of 14.28 is considered compare with the five-year average of -34.90.
P/E
EV/EBITDA
P/S
P/B
P/E
bubble
P/E

HCAT Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
HCAT.O
Health Catalyst Inc
14.28
Average P/E: 35.51
37.16%
290.67M
stocks logo
KLTR.O
Kaltura Inc
loss
Average P/E: 35.51
48.41%
285.16M
stocks logo
EGHT.O
8x8 Inc
0.00
Average P/E: 35.51
112.86%
257.02M
stocks logo
BKSY.N
Blacksky Technology Inc
loss
Average P/E: 35.51
278.42M
stocks logo
MTLS.O
Materialise NV
56.75
Average P/E: 35.51
650.45%
309.22M
stocks logo
NRDY.N
Nerdy Inc
loss
Average P/E: 35.51
-62.84%
285.69M

HCAT Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

HCAT FAQs

Is HCAT currently overvalued based on its P/E ratio?

According to the provided data, HCAT's 5-year historical average forward P/E ratio is -34.90. HCAT forward P/E ratio is 14.28, which is categorized as Fair.

What is the significance of the EV/EBITDA ratio for HCAT?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has HCAT's Price to Sales (PS) ratio evolved?

The PS ratio decreased from 1.59 to 1.39, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for HCAT's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

HCAT PE Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PE
-34.90
Current PE
14.28
Overvalued PE
79.47
Undervalued PE
-149.27

HCAT EV/EBITDA Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average EV
-98.39
Current EV
7.96
Overvalued EV
53.68
Undervalued EV
-250.45

HCAT P/S Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PS
4.25
Current PS
0.93
Overvalued PS
7.33
Undervalued PS
1.16

HCAT Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
HCAT.O
Health Catalyst Inc
14.28
Average P/E: 35.51
37.16%
290.67M
stocks logo
KLTR.O
Kaltura Inc
loss
Average P/E: 35.51
48.41%
285.16M
stocks logo
EGHT.O
8x8 Inc
0.00
Average P/E: 35.51
112.86%
257.02M
stocks logo
BKSY.N
Blacksky Technology Inc
loss
Average P/E: 35.51
278.42M
stocks logo
MTLS.O
Materialise NV
56.75
Average P/E: 35.51
650.45%
309.22M
stocks logo
NRDY.N
Nerdy Inc
loss
Average P/E: 35.51
-62.84%
285.69M

HCAT Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is HCAT undervalued？Is HCAT overvalued compared to its competitors？

HCAT FAQs

Is HCAT currently overvalued based on its P/E ratio?

According to the provided data, HCAT's 5-year historical average forward P/E ratio is -34.90. HCAT forward P/E ratio is 14.28, which is categorized as Fair.

What is the significance of the EV/EBITDA ratio for HCAT?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has HCAT's Price to Sales (PS) ratio evolved?

The PS ratio decreased from 1.59 to 1.39, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for HCAT's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is HCAT undervalued？Is HCAT overvalued compared to its competitors？
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI Screener
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free